Literature DB >> 11934965

Bioavailable testosterone in men with rheumatoid arthritis-high frequency of hypogonadism.

B Tengstrand1, K Carlström, I Hafström.   

Abstract

OBJECTIVES: To study bioavailable testosterone (T) in men with rheumatoid arthritis (RA) by determining non-sex hormone-binding globulin (SHBG)-bound T (NST) under standardized conditions and to investigate if NST is related to disease variables.
METHODS: Basal serum concentrations of total T, SHBG and luteinizing hormone (LH) were measured in 104 men with RA, and the levels of NST as well as the quotient T/SHBG were calculated. The data were compared with those of 99 age-matched healthy men. The results were analysed separately for the age groups 30-49, 50-59 and 60-69 yr.
RESULTS: The RA men had lower NST levels than the healthy men in all age groups. T levels and the T/SHBG ratio were lower only in the age group 50-59 yr. SHBG did not differ significantly. LH was significantly lower in the patients than in the controls. Thirty-three of the 104 patients were considered to have hypogonadism compared with seven of the 99 healthy men. The only clinical variable apart from age that had a significant impact on NST was the Stanford Health Assessment Questionnaire (HAQ).
CONCLUSION: Men with RA had lower levels of bioavailable T and a large proportion were considered hypogonadal. The low levels of LH suggested a central origin of the relative hypoandrogenicity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11934965     DOI: 10.1093/rheumatology/41.3.285

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  12 in total

1.  Association between endogenous sex steroid hormones and inflammatory biomarkers in US men.

Authors:  K K Tsilidis; S Rohrmann; K A McGlynn; S J Nyante; D S Lopez; G Bradwin; M Feinleib; C E Joshu; N Kanarek; W G Nelson; E Selvin; E A Platz
Journal:  Andrology       Date:  2013-09-30       Impact factor: 3.842

2.  Hypogonadism and the risk of rheumatic autoimmune disease.

Authors:  Jacques Baillargeon; Soham Al Snih; Mukaila A Raji; Randall J Urban; Gulshan Sharma; Melinda Sheffield-Moore; David S Lopez; Gwen Baillargeon; Yong-Fang Kuo
Journal:  Clin Rheumatol       Date:  2016-06-20       Impact factor: 2.980

3.  Acute changes in circulating hormones in older patients with impaired ventricular function undergoing on-pump coronary artery bypass grafting.

Authors:  M Maggio; G P Ceda; G De Cicco; E Cattadori; S Visioli; F Ablondi; C Beghi; T Gherli; S Basaria; G Ceresini; G Valenti; L Ferrucci
Journal:  J Endocrinol Invest       Date:  2005-09       Impact factor: 4.256

Review 4.  Sexual and reproductive health in rheumatic disease.

Authors:  Monika Østensen
Journal:  Nat Rev Rheumatol       Date:  2017-07-06       Impact factor: 20.543

Review 5.  Autoimmune diseases and reproductive aging.

Authors:  Riley Bove
Journal:  Clin Immunol       Date:  2013-02-28       Impact factor: 3.969

6.  Methotrexate treatment ameliorated testicular suppression and anorexia related leptin reduction in rats with adjuvant arthritis.

Authors:  Jana Jurcovicova; Karol Svik; Sona Scsukova; Katarina Bauerova; Jozef Rovensky; Maria Stancikova
Journal:  Rheumatol Int       Date:  2009-01-21       Impact factor: 2.631

7.  Sex hormone-binding globulin and arthritis: a Mendelian randomization study.

Authors:  Zihao Qu; Jiawei Huang; Fangkun Yang; Jianqiao Hong; Wei Wang; Shigui Yan
Journal:  Arthritis Res Ther       Date:  2020-05-18       Impact factor: 5.156

Review 8.  Sexual Dimorphism in Innate Immunity: The Role of Sex Hormones and Epigenetics.

Authors:  Rebecca Shepherd; Ada S Cheung; Ken Pang; Richard Saffery; Boris Novakovic
Journal:  Front Immunol       Date:  2021-01-21       Impact factor: 7.561

Review 9.  The many faces of testosterone.

Authors:  Jerald Bain
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

Review 10.  Autoimmune Thyroid Disease in Specific Genetic Syndromes in Childhood and Adolescence.

Authors:  Eleni Magdalini Kyritsi; Christina Kanaka-Gantenbein
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-19       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.